Trial intelligence / Profile preview

Ivabradine for Endothelial Function in CAD Patients

NCT02681978Phase 4Completed

Sponsor
Università Campus Bio-Medico di Roma
Start
Feb 2014
Primary completion
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ivabradine in coronary artery disease (CAD), sponsored by Università Campus Bio-Medico di Roma. Started Feb 2014; status: completed.

02

Drugs

ivabradine
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT02681978.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02681978.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call